NCP Flanders
choose your programme
Horizon Europe

Horizon Europe is the main Research and Innovation Funding Programme of the European Commission.

Horizon 2020

Horizon 2020 is the previous Funding Programme. There are no longer calls, but projects can run until 2024.

Digital Europe

Digital Europe is a Funding Programme focused on bringing digital technology to businesses, citizens and administrations.

Other EU Funding

There are many other relevant EU funding programmes, managed by several agencies and directorates.

Cluster 2


Culture, Creativity & Inclusive Society

Cluster 2 will focus on the EU goals and priorities on enhancing democratic governance and citizens participation, on the safeguarding and promotion of cultural heritage and respond to and shape multifaceted social, economic, technological and cultural transformations.

Your NCP contact for this programme

Image of Man Hei To

Man Hei To

manhei.to@fwo.be

+32 2 550 15 55

About this programme

The challenges of cluster 2 are interconnected to each other and have been chosen because they respond to the most pressing social, political, economic and cultural concerns and expectations of the European citizens.

Cluster 2 will address the EU priorities and will enable decision makers to meet challenges, adopt new paradigms, and policies for change in a context of fast paced transformations, transitions and international interconnectedness.

The Cluster 2 Work Programme will mainly focus on three key challenges or destinations:

  • Destination 1 (Innovative Research on Democracy and Governance): actions under destination 1 will reinvigorate democratic governance and improve trust in democratic institutions. They will help to safeguard fundamental rights to empower active and inclusive citizenship.
  • Destination 2 (Innovative Research on the European Cultural Heritage and the Cultural and Creative Industries): activities under this destination will promote better access and engagement with cultural heritage and improve its protection, enhancement and restoration. Research and innovation will support sustainable growth and job creation through the cultural and creative industries and contribute to integrate them into the European industrial policy as drivers for innovation and competitiveness.
  • Destination 3 (Innovative Research on Social and Economic Transformations): actions in destination 3 will help to tackle social, economic and political inequalities, support human capital development and contribute to a comprehensive European strategy for inclusive growth.

 

Furthermore, cluster 2 will also use the multidisciplinary expertise of social sciences and humanities in order to better understand the fundamental contemporary transformations of society, economy, politics and culture.

Click to read more 
Hide text 

Latest news

Upcoming events

Work Programme & Calls

We offer a handy Excel file, weekly updated, containing an up-to-date overview of the Horizon Europe calls. call topics overview

Infosheets

Infosheets contain edited content on aspects related to this programme. They are reviewed at least yearly.

Documents

Documents contain additional information related to this programme, and are similar to related links.

    No documents available for this domain

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.